| Literature DB >> 27632063 |
Lukas Perkhofer1, Karolin Walter1, Ivan G Costa2, Maria C Romero Carrasco1, Tim Eiseler1, Susanne Hafner3, Felicitas Genze3, Martin Zenke4, Wendy Bergmann1, Anett Illing1, Meike Hohwieler1, Ralf Köhntop1, Qiong Lin4, Karl-Heinz Holzmann5, Thomas Seufferlein1, Martin Wagner1, Stefan Liebau6, Patrick C Hermann7, Alexander Kleger8, Martin Müller1.
Abstract
Cell fate decisions and pluripotency, but also malignancy depend on networks of key transcriptional regulators. The T-box transcription factor TBX3 has been implicated in the regulation of embryonic stem cell self-renewal and cardiogenesis. We have recently discovered that forced TBX3 expression in embryonic stem cells promotes mesendoderm specification directly by activating key lineage specification factors and indirectly by enhancing paracrine NODAL signalling. Interestingly, aberrant TBX3 expression is associated with breast cancer and melanoma formation. In other cancers, loss of TBX3 expression is associated with a more aggressive phenotype e.g. in gastric and cervical cancer. The precise function of TBX3 in pancreatic ductal adenocarcinoma remains to be determined. In the current study we provide conclusive evidence for TBX3 overexpression in pancreatic cancer samples as compared to healthy tissue. While proliferation remains unaltered, forced TBX3 expression strongly increases migration and invasion, but also angiogenesis in vitro and in vivo. Finally, we describe the TBX3-dependency of cancer stem cells that perpetuate themselves through an autocrine TBX3-ACTIVIN/NODAL signalling loop to sustain stemness. Thus, TBX3 is a new key player among pluripotency-related genes driving cancer formation.Entities:
Keywords: Cancer stem cells; Development; Pancreas; Pancreatic adenocarcinoma; TBX3
Mesh:
Substances:
Year: 2016 PMID: 27632063 DOI: 10.1016/j.scr.2016.08.007
Source DB: PubMed Journal: Stem Cell Res ISSN: 1873-5061 Impact factor: 2.020